Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1210/jc.2012-4018
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1982888437
